Breast tumour response to primary chemotherapy predicts local and distant control as well as survival
- 1 November 1995
- journal article
- clinical trial
- Published by Elsevier BV in European Journal Of Cancer
- Vol. 31 (12), 1969-1975
- https://doi.org/10.1016/0959-8049(95)00454-8
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Neoadjuvant versus adjuvant chemotherapy in premenopausal patients with tumours considered too large for breast conserving surgery: Preliminary results of a randomised trial: S6European Journal Of Cancer, 1994
- c-erbB-2 Expression and Response to Adjuvant Therapy in Women with Node-Positive Early Breast CancerNew England Journal of Medicine, 1994
- Antineoplastic Drug Resistance and Breast CancerAnnals of the New York Academy of Sciences, 1993
- Age as prognostic factor in premenopausal breast carcinomaThe Lancet, 1993
- HER-2/neu in node-negative breast cancer: prognostic significance of overexpression influenced by the presence of in situ carcinoma.Journal of Clinical Oncology, 1992
- Ploidy Analysis and S-Phase Fraction Determination by Flow Cytometry of Invasive Adenocarcinomas of the BreastThe American Journal of Surgical Pathology, 1991
- P-Glycoprotein expression in treated and untreated human breast cancerBritish Journal of Cancer, 1989
- Correlation of Pretreatment Proliferative Activity of Breast Cancer With the Response to Cytotoxic ChemotherapyJNCI Journal of the National Cancer Institute, 1989
- DNA flow cytometry applied to fine needle sampling of human breast cancerCancer, 1988
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958